Ligand validation:6RSI

EVB: sulfonato-calix[8]arene

EVB is a Ligand Of Interest in 6RSI designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6RSI_EVB_A_203	50%	30%	0.222	0.976	2.07	0.87	28	4	0	0	100%	1
6RSI_EVB_A_202	49%	28%	0.223	0.973	2.12	0.92	27	6	0	0	100%	1
6RSI_EVB_A_204	5%	25%	0.348	0.754	2.27	0.96	31	5	0	0	100%	0.9
6GD7_EVB_A_202	96%	27%	0.065	0.975	2	1.11	8	10	0	0	100%	1
6GD6_EVB_A_202	90%	32%	0.086	0.968	1.71	1.11	9	10	0	0	100%	1
6GD8_EVB_A_202	85%	25%	0.112	0.977	2.25	1	8	10	1	0	100%	1
6RSK_EVB_A_202	74%	29%	0.152	0.983	2.07	0.93	28	5	0	0	100%	1
6GD9_EVB_A_203	67%	27%	0.166	0.976	2.21	0.91	8	3	0	0	100%	1
8Q6B_EVB_A_104	92%	92%	0.079	0.97	0.28	0.24	-	-	0	0	100%	1
6HAJ_EVB_B_101	90%	27%	0.07	0.951	1.96	1.14	8	14	0	0	100%	1
6Z5X_EVB_A_101	87%	88%	0.09	0.961	0.33	0.33	-	1	1	0	100%	1

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.